Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Any subject with coexisting kidney disease and type 1 or type 2 diabetes is eligible for the study, including: newly-diagnosed subjects, insulin naïve and subjects who have received insulin or an insulin analogue before
Subjects with kidney disease (stage I-IV) including transplant patients will be eligible for the study, if initiated with NovoRapid™"
You may not be if
Subjects who are unlikely to comply with protocol requirements, e.g., uncooperative attitude, inability to return for the final visit
Subjects with stage V of chronic kidney disease
Subjects who previously enrolled in this study
Known or suspected allergy to trial product(s) or related products
